The genetic diversity of cystinuria in a UK population of patients
- 12 March 2015
- journal article
- research article
- Published by Wiley in BJU International
- Vol. 116 (1) , 109-116
Abstract
Objective: To examine the genetic mutations in the first UK cohort of patients with cystinuria with preliminary genotype/phenotype correlation. Patients and Methods: DNA sequencing and multiplex ligation‐dependent probe amplification ( MLPA ) were used to identify the mutations in 74 patients in a specialist cystinuria clinic in the UK . Patients with type A cystinuria were classified into two groups: Group M patients had at least one missense mutation and Group N patients had two alleles of all other types of mutations including frameshift, splice site, nonsense, deletions and duplications. The levels of urinary dibasic amino acids, age at presentation of disease, number of stone episodes and interventions were compared between patients in the two groups using the Mann–Whitney U ‐test. Results: In all, 41 patients had type A cystinuria, including one patient with a variant of unknown significance and 23 patients had type B cystinuria, including six patients with variants of unknown significance. One patient had three sequence variants in SLC 7A9; however, two are of unknown significance. Three patients had type AB cystinuria. Three had a single mutation in SLC 7A9. No identified mutations were found in three patients in either gene. There were a total of 88 mutations in SLC 3A1 and 55 mutations in SLC 7A9. There were 23 pathogenic mutations identified in our UK cohort of patients not previously published. In patients with type A cystinuria, the presence of a missense mutation correlated to lower levels of urinary lysine (mean [ se ] 611.9 [22.65] vs 752.3 [46.39] millimoles per mole of creatinine [m m / MC ]; P =0.02), arginine (194.8 [24.83] vs 397.7 [15.32] m m / MC ; P P =0.02). There was no difference in the levels of urinary cystine (182.1 [8.89] vs 207.2 [19.23] m m / MC ; P =0.23). Conclusions: We have characterised the genetic diversity of cystinuria in a UK population including 23 pathogenic mutations not previously published. Patients with at least one missense mutation in SLC 3A1 had significantly lower levels of lysine, arginine, and ornithine but not cystine than patients with all other combinations of mutations.Keywords
Funding Information
- Guys and St Thomas' Charity
This publication has 25 references indexed in Scilit:
- Pathophysiology and treatment of cystinuriaNature Reviews Nephrology, 2010
- Large rearrangements detected by MLPA, point mutations, and survey of the frequency of mutations within the SLC3A1 and SLC7A9 genes in a cohort of 172 cystinuric Italian patientsMolecular Genetics and Metabolism, 2010
- Variaciones en el gen SLC7A9: impacto de trece mutaciones frecuentes en la etiología de la cistinuria en población mediterránea españolaMedicina Clinica, 2006
- Reduced renal function and benefits of treatment in cystinuria vs other forms of nephrolithiasisBJU International, 2006
- A novel missense mutation of SLC7A9 frequent in Japanese cystinuria cases affecting the C-terminus of the transporterKidney International, 2006
- Mutation Analysis of SLC7A9 in Cystinuria Patients in SwedenGenetic Testing, 2003
- Identification of 12 novel mutations in the SLC3A1 gene in Swedish cystinuria patientsHuman Mutation, 2001
- Functional analysis of mutations in SLC7A9, and genotype–phenotype correlation in non-Type I cystinuriaHuman Molecular Genetics, 2001
- Cystinuria: Defective Intestinal Transport of Dibasic Amino Acids and Cystine*Journal of Clinical Investigation, 1965
- Cystinuria: In vitro Demonstration of an Intestinal Transport DefectScience, 1964